Xenon Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ CA98420N1050

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Gover Justin D.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Gover Justin D. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:XENE / Xenon Pharmaceuticals Inc. Director 0
Chief Executive Officer, Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Gover Justin D.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb XENE / Xenon Pharmaceuticals Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i XENE / Xenon Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XENE / Xenon Pharmaceuticals Inc. Insider Trades
Insidersalg XENE / Xenon Pharmaceuticals Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i XENE / Xenon Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XENE / Xenon Pharmaceuticals Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Gover Justin D. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2023-08-10 3 XENE Xenon Pharmaceuticals Inc.
No securities are beneficially owned.
0
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -263.184 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -164.496 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -479.844 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -287.904 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -55.488 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -12.492 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -226.752 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -34.008 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -22.440 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -30.936 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -119.472 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -147.624 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -142.344 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -213.240 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -75.864 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -17.508 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
D - Sale to Issuer -1.867.308 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
D - Sale to Issuer -456.048 0 -100,00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
D - Sale to Issuer -222.773 0 -100,00
2021-03-22 2021-03-19 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
G - Gift -276.000 1.867.308 -12,88
2021-03-04 2021-03-02 4 GWPH GW PHARMACEUTICALS PLC
Share Options
A - Award 164.496 164.496
2021-03-04 2021-03-02 4 GWPH GW PHARMACEUTICALS PLC
Share Options
A - Award 263.184 263.184
2021-03-02 2021-03-01 4 GWPH GW PHARMACEUTICALS PLC
Share Options
M - Exercise -17.004 0 -100,00
2021-03-02 2021-03-01 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
F - Taxes -8.412 222.773 -3,64 17,85 -150.154 3.976.498
2021-03-02 2021-03-01 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 17.004 231.185 7,94 0,00 24 324
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Share Options
M - Exercise -101.436 0 -100,00
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Share Options
M - Exercise -24 0 -100,00
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Share Options
M - Exercise -299.196 0 -100,00
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Share Options
M - Exercise -22.440 0 -100,00
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
F - Taxes -49.992 214.181 -18,92 17,90 -894.857 3.833.840
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 101.412 264.173 62,31 0,00 142 370
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
F - Taxes -12 162.761 -0,01 17,90 -215 2.913.422
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 24 162.773 0,01 0,00 0 228
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
F - Taxes -147.806 162.749 -47,59 17,90 -2.645.727 2.913.207
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 299.196 310.555 2.634,00 0,00 419 435
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
F - Taxes -11.086 11.359 -49,39 17,90 -198.439 203.326
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 22.440 22.445 448.800,00 0,00 31 31
2021-02-24 2021-02-22 4 GWPH GW PHARMACEUTICALS PLC
Share Options
A - Award 263.184 263.184
2021-02-24 2021-02-22 4 GWPH GW PHARMACEUTICALS PLC
Share Options
A - Award 164.496 164.496
2021-01-06 2020-12-31 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
G - Gift 456.048 456.048
2021-01-06 2020-12-31 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
G - Gift -456.048 5 -100,00
2020-11-17 2020-11-17 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -42.708 101.409 -29,63
2020-11-17 2020-11-17 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -42.708 456.053 -8,56 10,03 -428.361 4.574.212
2020-11-17 2020-11-17 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 42.708 498.761 9,36 0,00 56 648
2020-11-17 2020-11-16 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -22.800 144.117 -13,66
2020-11-17 2020-11-16 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -22.800 456.053 -4,76 10,02 -228.456 4.569.651
2020-11-17 2020-11-16 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 22.800 478.853 5,00 0,00 30 623
2020-11-17 2020-11-13 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -3.924 10 -99,75
2020-11-17 2020-11-13 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -39.060 166.917 -18,96
2020-11-17 2020-11-13 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -42.984 456.053 -8,61 10,01 -430.270 4.565.091
2020-11-17 2020-11-13 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 3.924 499.037 0,79 0,00 5 649
2020-11-17 2020-11-13 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 39.060 495.113 8,56 0,00 51 644
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -27.591 205.977 -11,81
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -13.917 0 -100,00
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -22.800 3.934 -85,28
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -64.308 456.053 -12,36 10,01 -643.723 4.565.091
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 27.591 520.361 5,60 0,00 36 676
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 13.917 492.770 2,91 0,00 18 641
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 22.800 478.853 5,00 0,00 30 623
2020-11-12 2020-11-09 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -3.600 13.917 -20,55
2020-11-12 2020-11-09 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -3.600 13.917 -20,55
2020-11-12 2020-11-09 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -7.200 456.053 -1,55 10,00 -72.000 4.560.530
2020-11-12 2020-11-09 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 3.600 463.253 0,78 0,00 5 602
2020-11-12 2020-11-09 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 3.600 459.653 0,79 0,00 5 598
2020-06-17 2020-06-15 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -4.164 0 -100,00
2020-06-17 2020-06-15 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
F - Taxes -2.076 456.053 -0,45 10,23 -21.237 4.665.422
2020-06-17 2020-06-15 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 4.164 458.129 0,92 0,00 5 596
2020-06-08 2020-06-04 4 GWPH GW PHARMACEUTICALS PLC
Share Options
A - Award 287.904 287.904
2020-06-08 2020-06-04 4 GWPH GW PHARMACEUTICALS PLC
Share Options
A - Award 480 480
2020-03-04 2020-03-02 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -17.510 7 -99,96
2020-03-04 2020-03-02 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -30.334 0 -100,00
2020-03-04 2020-03-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -8.400 566.513 -1,46 8,40 -70.560 4.758.709
2020-03-04 2020-03-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -24.456 574.913 -4,08 8,31 -203.229 4.777.527
2020-03-04 2020-03-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 17.510 599.369 3,01 0,00 23 779
2020-03-04 2020-03-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 30.334 581.859 5,50 0,00 39 756
2020-02-28 2020-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -876 551.525 -0,16 9,21 -8.068 5.079.545
2020-02-28 2020-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -1.644 552.401 -0,30 9,17 -15.075 5.065.517
2020-02-28 2020-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -9.480 554.045 -1,68 9,01 -85.415 4.991.945
2020-02-05 2020-02-03 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -202.224 7 -100,00
2020-02-05 2020-02-03 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -19.548 563.525 -3,35 9,71 -189.811 5.471.828
2020-02-05 2020-02-03 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -110.964 583.073 -15,99 9,63 -1.068.583 5.614.993
2020-02-05 2020-02-03 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -71.712 694.037 -9,36 9,57 -686.284 6.641.934
2020-02-05 2020-02-03 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 202.224 765.749 35,89 0,00 263 995
2019-12-19 2019-12-17 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -10.668 11 -99,90
2019-12-19 2019-12-17 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -5.340 563.525 -0,94 9,17 -48.968 5.167.524
2019-12-19 2019-12-17 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 10.668 568.865 1,91 0,00 14 740
2019-06-18 2019-06-14 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 55.488 55.488
2019-06-18 2019-06-14 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 30.936 30.936
2019-06-18 2019-06-14 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
A - Award 16.656 558.197 3,08 0,00 22 726
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -202.224 202.231 -50,00
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -6.012 541.541 -1,10 15,49 -93.126 8.388.470
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -19.284 547.553 -3,40 15,43 -297.552 8.448.743
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -40.728 566.837 -6,70 15,35 -625.175 8.700.948
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -56.736 607.565 -8,54 15,25 -865.224 9.265.366
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -26.784 664.301 -3,88 15,17 -406.313 10.077.446
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -52.680 691.085 -7,08 15,08 -794.414 10.421.562
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 202.224 743.765 37,34 0,00 263 967
2019-03-19 2019-03-15 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -30.334 60.668 -33,33
2019-03-19 2019-03-15 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -17.517 0 -100,00
2019-03-19 2019-03-15 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -23.400 541.541 -4,14 14,01 -327.834 7.586.989
2019-03-19 2019-03-15 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
D - Sale to Issuer -19 564.941 0,00 13,88 -264 7.841.381
2019-03-19 2019-03-15 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 47.851 564.960 9,25 0,00 62 734
2019-03-05 2019-03-01 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 17.004 17.004
2019-03-05 2019-03-01 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 17.004 17.004
2019-03-05 2019-03-01 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 17.004 17.004
2019-03-05 2019-03-01 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 17.004 17.004
2019-03-05 2019-03-01 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 226.752 226.752
2019-03-05 2019-03-01 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 119.472 119.472
2019-02-28 2019-02-26 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -22.440 0 -100,00
2019-02-28 2019-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -96 381.773 -0,03 12,28 -1.179 4.688.172
2019-02-28 2019-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -11.016 381.869 -2,80 12,45 -137.149 4.754.269
2019-02-28 2019-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 22.440 392.885 6,06 0,00 29 511
2019-02-15 2019-02-13 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -22.620 370.445 -5,75 12,50 -282.750 4.630.562
2019-01-04 2019-01-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -1.200 393.065 -0,30 8,52 -10.224 3.348.914
2019-01-04 2019-01-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -14.220 394.265 -3,48 8,43 -119.875 3.323.654
2019-01-04 2019-01-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -1.200 408.485 -0,29 8,25 -9.900 3.370.001
2019-01-04 2019-01-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -3.600 409.685 -0,87 8,14 -29.304 3.334.836
2019-01-04 2019-01-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -2.400 413.285 -0,58 7,96 -19.104 3.289.749
2018-12-26 2018-12-20 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -45.240 0 -100,00
2018-12-26 2018-12-20 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 45.240 415.685 12,21 0,00 59 540
2018-10-01 3 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
2.884.204
2018-10-01 3 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
4.657.073
2018-10-01 3 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
2.884.204
2018-10-01 3 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
4.657.073
2018-10-01 3 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
2.884.204
2018-10-01 3 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
4.657.073
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)